Detecting HCV infection by means of mass population SARS-CoV-2 screening: A pilot experience in Northern Italy.
作者信息
Giacomelli Andrea, Pagani Gabriele, Conti Federico, Bassoli Cinzia, Galli Massimo
机构信息
Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, Università degli Studi di Milano, Italy.
Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, Università degli Studi di Milano, Italy.
出版信息
J Hepatol. 2021 Aug;75(2):484-486. doi: 10.1016/j.jhep.2020.12.026. Epub 2021 Jan 13.
Abstract
摘要
相似文献
1
Detecting HCV infection by means of mass population SARS-CoV-2 screening: A pilot experience in Northern Italy.通过大规模人群SARS-CoV-2筛查检测丙型肝炎病毒感染：意大利北部的一项试点经验。
J Hepatol. 2021 Aug;75(2):484-486. doi: 10.1016/j.jhep.2020.12.026. Epub 2021 Jan 13.
2
HCV point of care screening in people tested for SARS-CoV-2 in a social-housing neighbourhood of Milan, Italy.在意大利米兰一个社会住房社区中，对接受过新冠病毒检测的人群进行丙型肝炎病毒即时检测。
Liver Int. 2023 Jan;43(1):251-255. doi: 10.1111/liv.15375. Epub 2022 Aug 8.
3
Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: A cohort study.意大利南部城市地区丙型肝炎病毒（HCV）和严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染的联合筛查：一项队列研究。
J Viral Hepat. 2022 Feb;29(2):171-173. doi: 10.1111/jvh.13623. Epub 2021 Oct 6.
4
Hepatitis C screening during SARS-CoV-2 testing or vaccination. Experience in an area of southern Italy in the province of Salerno.在进行2019冠状病毒病检测或疫苗接种期间的丙型肝炎筛查。意大利南部萨勒诺省一个地区的经验。
Liver Int. 2022 Jun;42(6):1467-1469. doi: 10.1111/liv.15273. Epub 2022 Apr 23.
5
HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination?在进行新冠病毒检测期间以及整个新冠疫苗接种过程中都能够检测丙肝病毒吗？
J Hepatol. 2021 Aug;75(2):486-487. doi: 10.1016/j.jhep.2021.04.043. Epub 2021 May 7.
6
SARS-CoV-2 massive testing: A window of opportunity to catch up with HCV elimination.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大规模检测：追赶丙型肝炎病毒消除目标的机遇之窗。
J Hepatol. 2021 Apr;74(4):966-967. doi: 10.1016/j.jhep.2020.10.001. Epub 2020 Oct 9.
7
Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?新冠疫情对巴西丙型肝炎诊断的影响：全球丙型肝炎消除战略是否面临风险？
J Hepatol. 2022 Feb;76(2):470-472. doi: 10.1016/j.jhep.2021.08.005. Epub 2021 Aug 24.
8
Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation.意大利实现丙型肝炎病毒（HCV）消除的里程碑：从免费筛查到 HCV 自由国家的区域路线图。
Dig Liver Dis. 2022 Feb;54(2):237-242. doi: 10.1016/j.dld.2021.03.026. Epub 2021 Apr 27.
9
Is elimination of HCV in 2030 realistic in Central Europe.2030 年在中欧消除 HCV 是否现实。
Liver Int. 2021 Jun;41 Suppl 1:56-60. doi: 10.1111/liv.14834.
10
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].[意大利北部皮埃蒙特大区博尔戈塞西亚人群中抗SARS-CoV-2 IgG/IgM抗体的血清流行率：封锁后时期的监测策略？]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):200-206. doi: 10.19191/EP20.5-6.S2.119.
引用本文的文献
1
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper.COVID-19 对肝脏的影响以及对慢性肝病、肝胆癌和肝移植患者的治疗影响：EASL 最新立场文件。
J Hepatol. 2022 Oct;77(4):1161-1197. doi: 10.1016/j.jhep.2022.07.008. Epub 2022 Jul 20.
2
Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions.意大利南部消除丙型肝炎：不同医院科室住院患者 HCV 筛查和护理衔接模型。
Viruses. 2022 May 19;14(5):1096. doi: 10.3390/v14051096.
3
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic-Standardized National Screening or One Tailored to Local Epidemiology?意大利南部高流行地区丙型肝炎病毒和乙型肝炎病毒的流行病学：新冠疫情带来的机遇——全国标准化筛查还是根据当地流行病学情况定制筛查？
Biology (Basel). 2022 Apr 16;11(4):609. doi: 10.3390/biology11040609.
4
Hepatitis C screening during SARS-CoV-2 testing or vaccination. Experience in an area of southern Italy in the province of Salerno.在进行2019冠状病毒病检测或疫苗接种期间的丙型肝炎筛查。意大利南部萨勒诺省一个地区的经验。
Liver Int. 2022 Jun;42(6):1467-1469. doi: 10.1111/liv.15273. Epub 2022 Apr 23.
5
Impact of COVID-19 on liver disease: From the experimental to the clinic perspective.2019年冠状病毒病对肝脏疾病的影响：从实验到临床视角
World J Virol. 2021 Nov 25;10(6):301-311. doi: 10.5501/wjv.v10.i6.301.
6
HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination?在进行新冠病毒检测期间以及整个新冠疫苗接种过程中都能够检测丙肝病毒吗？
J Hepatol. 2021 Aug;75(2):486-487. doi: 10.1016/j.jhep.2021.04.043. Epub 2021 May 7.
7
Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges.细胞因子风暴和全身炎症对感染SARS-CoV-2的肝功能损害患者的影响：前瞻性治疗挑战。
World J Gastroenterol. 2021 Apr 21;27(15):1531-1552. doi: 10.3748/wjg.v27.i15.1531.
8
Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world.让我们利用新冠疫苗接种在西班牙、欧洲乃至全球范围内筛查丙型肝炎。
J Hepatol. 2021 Jul;75(1):224-226. doi: 10.1016/j.jhep.2021.03.009. Epub 2021 Mar 20.
本文引用的文献
1
SARS-CoV-2 massive testing: A window of opportunity to catch up with HCV elimination.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大规模检测：追赶丙型肝炎病毒消除目标的机遇之窗。
J Hepatol. 2021 Apr;74(4):966-967. doi: 10.1016/j.jhep.2020.10.001. Epub 2020 Oct 9.
2
Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的血清流行率随年龄显著变化：大规模人群筛查的初步结果。
J Infect. 2020 Dec;81(6):e10-e12. doi: 10.1016/j.jinf.2020.09.021. Epub 2020 Sep 19.
3
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic.2019冠状病毒病对肝病患者护理的影响：大流行6个月后的欧洲肝脏研究学会-欧洲临床微生物学与传染病学会立场文件
JHEP Rep. 2020 Oct;2(5):100169. doi: 10.1016/j.jhepr.2020.100169. Epub 2020 Aug 4.
4
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.西班牙 2020 年人群血清流行病学研究（ENE-COVID）：全国范围内基于人群的血清流行病学研究。
Lancet. 2020 Aug 22;396(10250):535-544. doi: 10.1016/S0140-6736(20)31483-5. Epub 2020 Jul 6.
5
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.丙型肝炎病毒流行率以及到 2030 年实现世界卫生组织在欧盟消除目标所需的干预水平：建模研究。
Lancet Gastroenterol Hepatol. 2017 May;2(5):325-336. doi: 10.1016/S2468-1253(17)30045-6. Epub 2017 Mar 15.
6
Global epidemiology and genotype distribution of the hepatitis C virus infection.全球丙型肝炎病毒感染的流行病学和基因型分布。
J Hepatol. 2014 Nov;61(1 Suppl):S45-57. doi: 10.1016/j.jhep.2014.07.027. Epub 2014 Jul 30.
7
Performance of the OraQuick HCV rapid antibody test for screening exposed patients in a hepatitis C outbreak investigation.在丙型肝炎疫情调查中，使用 OraQuick HCV 快速抗体检测法对暴露患者进行筛查的性能。
J Clin Microbiol. 2014 Jul;52(7):2650-2. doi: 10.1128/JCM.00132-14. Epub 2014 Apr 30.
8
Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.慢性丙型肝炎患者经干扰素治疗根除丙型肝炎病毒（HCV）感染后HCV抗体状态的变化。
Clin Infect Dis. 2005 Mar 15;40(6):e49-54. doi: 10.1086/428128. Epub 2005 Feb 18.
9
Seroprevalence, viremia and genotype distribution of hepatitis C virus: a community-based population study in northern Italy.丙型肝炎病毒的血清流行率、病毒血症及基因型分布：意大利北部一项基于社区的人群研究。
Infection. 2002 Jan;30(1):7-12. doi: 10.1007/s15010-001-1197-4.
Zotero 插件